2.A.6.2.15 Multidrug efflux pump, MexCD-OprJ (exports β-lactams, fluoroquinolones, tetracycline, macrolides, chloramphenicol, biocides, including levofloxacin, carbenicillin, aztreonam, ceftazidime, cefepime, cefoperazone, piperacillin, erythromycin, azithromycin, chloramphenicol, etc.; Mao et al., 2002). Functions with MexC (MFP) and OprJ (OMF) as indicated above (Mao et al., 2002; Poole, 2008; Lorusso et al. 2022). MexCD-OprJ is one of four primary drug exporters in P. aeruginosa (Lorusso et al. 2022). Collateral sensitivity (CS) is an evolutionary trade-off traditionally
linked to the mutational acquisition of antibiotic resistance (AR) (Hernando-Amado et al. 2023).
However, AR can be temporally induced. Mutational
acquisition of ciprofloxacin resistance leads to robust CS to tobramycin
in pre-existing antibiotic-resistant mutants of Pseudomonas aeruginosa.
Further, the strength of this phenotype is higher when nfxB mutants,
over-producing the efflux pump MexCD-OprJ, are selected. Hernando-Amado et al. 2023 induced
transient nfxB-mediated ciprofloxacin resistance by using the
antiseptic dequalinium chloride. Notably, non-inherited induction of AR
renders transient tobramycin CS in the analyzed antibiotic-resistant
mutants and clinical isolates, including tobramycin-resistant isolates.
Further, by combining tobramycin with dequalinium chloride we drive
these strains to extinction. Our results support that transient CS could
allow the design of new evolutionary strategies to tackle
antibiotic-resistant infections, avoiding the acquisition of AR
mutations on which inherited CS depends (Hernando-Amado et al. 2023). The type of quinolone resistance mechanism is related to the frequency of
MDRP and the risk of MDRP incidence is highly dependent on the
order of exposure to gentamicin and ciprofloxacin (Yasuda et al. 2023).
|
Accession Number: | Q51396 |
Protein Name: | Efflux pump membrane transporter |
Length: | 1043 |
Molecular Weight: | 112068.00 |
Species: | Pseudomonas aeruginosa [287] |
Number of TMSs: | 12 |
Location1 / Topology2 / Orientation3: |
Cell inner membrane1 / Multi-pass membrane protein2 |
Substrate |
macrolide, fluoroquinolone antibiotic, levofloxacin, ciprofloxacin, chloramphenicol, beta-lactam, cefepime, aztreonam, tetracycline, tobramycin, erythromycin A, carbenicillin, ceftazidime, piperacillin, cefoperazone, azithromycin |
---|
1: MSEFFIKRPN FAWVVALFIS LGGLLVISKL PVAQYPNVAP PQITITATYP GASAKVLVDS
61: VTSVLEESLN GAKGLLYFES TNNSNGTAEI VVTFEPGTDP DLAQVDVQNR LKKAEARMPQ
121: AVLTQGLQVE QTSAGFLLIY ALSYKEGAQR SDTTALGDYA ARNINNELRR LPGVGKLQFF
181: SSEAAMRVWI DPQKLVGFGL SIDDVSNAIR GQNVQVPAGA FGSAPGSSAQ ELTATLAVKG
241: TLDDPQEFGQ VVLRANEDGS LVPARRCRAP GTRQGELQHF LATERHAHRG RGYPAVARGQ
301: RDPDPTLVKQ RLAELSAFFP EDMQYSVPYD TSRFVDVAIE KVIHTLIEAM VLVFLVMFLF
361: LENVRYTLIP SIVVPVCLLG TLMVMYLLGF SVNMMTMFGM VLAIGILVDD AIVVVENVER
421: IMAEEGISPA EATVKAMKQV SGAIVGITLV LSAVFLPLAF MAGSVGVIYQ QFSVSLAVSI
481: LFSGFLALTF TPALCATLFK PIPEGHHEKR GFFGAFNRGF ARVTERYSLL NSKLVARAGR
541: FMLVYAGLVA MLGYFYLRLP EAFVPAEDLG YMVVDVQLPP GASRVRTDAT GEELERFLKS
601: REAVASVFLI SGFSFSGQGD NAALAFPTFK DWSERGAEQS SAAEIAALNE HFALPDDGTV
661: MAVSPPPING LGNSGGFALR LMDRSGVGRE ALLQARDTLL GEIQTNPKFL YAMMEGLAEA
721: PQLRLLIDRE KARALGVSFE TISGTLSAAF GSEVINDFTN AGRQQRVVIQ AEQGNRMTPE
781: SVLELYVPNA AGNLVPLSAF VSVKWEEGPV QLVRYNGYPS IRIVGDAAPG FSTGEAMAEM
841: ERLASQLPAG IGYEWTGLSY QEKVSAGQAT SLFALAILVV FLLLVALYES WSIPLSVMLI
901: VPIGAIGAVL AVMVSGMSND VYFKVGLITI IGLSAKNAIL IVEFAKELWE QGHSLRDAAI
961: EAARLRFRPI IMTSMAFILG VIPLALASGA GAASQRAIGT GVIGGMLSAT FLGVLFVPIC
1021: FVWLLSLLRS KPAPIEQAAS AGE